CHRISTINA GRAHAM: Open Payments
NPI 1164898201 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 45 payments from 9 companies in 2025. Trend: 2023 $172 · 2024 $1,237 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $326 |
| Alkermes, Inc. | 8 | $225 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $224 |
| E.R. Squibb & Sons, L.L.C. | 3 | $153 |
| ABBVIE INC. | 13 | $148 |
| Teva Pharmaceuticals USA, Inc. | 2 | $136 |
| Neurocrine BioSciences, Inc. | 3 | $62 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: Auvelity, CAPLYTA, COBENFY, VRAYLAR, UZEDY, LYBALVI, ARISTADA, INGREZZA.
Industry payments across SD — which companies pay providers there.
